Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy

Final appraisal determination

Final appraisal determination document (PDF 446 KB)

Appraisal consultation

Committee papers information

Committee papers (PDF 9.3 MB)

Appraisal consultation document

Final scope

Final matrix

NICEs response to comments on the draft scope and provisional matrix

Equality impact assessment

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): provisional matrix (pre-referral) July 2014

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): draft scope for consultation (pre-referral) July 2014